Category : Search result: pharmaceutical industry


Fox Host Debunks Trump's 600% Drug Price Cut Claim

A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.

Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Pfizer 2026 profit forecast below expectations

Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.

China's Biopharma Surge Challenges Global Drug Leaders

China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Grey Bruce drug disposal nets meds for hockey tickets

Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.

Dipharma's Novel Method Detects Nitrosamine Risks

Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.

Novo Nordisk Alzheimer's Drug Trials Fail

Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.

Eli Lilly Reaches $1 Trillion Valuation Milestone

Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.

Denmark compensates for Novo Nordisk vision loss

Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.

J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

Barbados Launches US$200M Life Sciences Hub

Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.

Pfizer wins $10B obesity drug takeover battle

Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.

Trump's Plan to Slash Obesity Drug Prices

Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.

Trump's Drug Price Plan Backfires, Helps Democrats

Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.

Canada Goose Q2 Loss Despite Revenue Growth

Canadian luxury outerwear giant Canada Goose reports surprising second-quarter loss despite 1% revenue increase to $281.1 million, as the company navigates wholesale challenges and invests in future growth strategies.

Canada's Housing Crisis Worsens: Budget 2025 Responds

As Canada's housing shortage reaches critical levels, Budget 2025 introduces aggressive measures to boost construction. Discover how new funding and policy changes aim to tackle the affordability crisis head-on.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

WIFF's Record Year: 231 Films, Thousands of Fans

The Windsor International Film Festival celebrates its biggest year ever with record-breaking attendance, expanded programming, and unprecedented community engagement across 10 vibrant days of cinema.

Seal Diet Study Reignites NL Fisheries Debate

New research reveals seals are consuming large quantities of cod, reigniting the contentious discussion about seal management in Atlantic Canada's struggling fishing industry.

Page 1 of 4